The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Latsh N.Yu.

Pirogov National Research Medical University

Pavlicov A.E.

Pirogov Russian National Research Medical University

Changes in venous circulation in patients with multiple sclerosis

Authors:

Latsh N.Yu., Pavlicov A.E.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7‑2): 22‑28

DOI: 10.17116/jnevro202312307222

Views: 1492

Downloaded: 16

Download PDF (RU)
Contact the author
Table of contents

CHANGES IN VENOUS CIRCULATION IN PATIENTS WITH MULTIPLE SCLEROSIS
CHANGES IN VENOUS CIRCULATION IN PATIENTS WITH MULTIPLE SCLEROSIS

To cite this article:

Latsh NYu, Pavlicov AE. Changes in venous circulation in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7‑2):22‑28. (In Russ.)
https://doi.org/10.17116/jnevro202312307222

 
Подписка 2025-2 (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Close metadata
Recommended articles:
Biobanking in clinical trials invo­lving multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7-2):7-15
The effe­ctiveness of tele-rehabilitation for patients with multiple scle­rosis during the COVID-19 pandemic in 2020—2021 was evaluated in this study. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(3):75-81
Long-term effi­cacy and safety of divo­zilimab during 2-year treatment of multiple scle­rosis patients in randomized double-blind placebo-controlled clinical trial BCD-132-4/MIRANTIBUS. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):86-96
A case of COVID-associated ence­phalopathy in a patient with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):159-163
Opti­cal cohe­rence tomo­graphy angiography in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(2):63-70
A role of cere­brovascular diseases in the progression of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(5):53-57
Opti­cal cohe­rence tomo­graphy in the diagnosis of multiple scle­rosis. Russian Annals of Ophthalmology. 2024;(3):59-68
Questionnaires for arm function asse­ssment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):36-42
Features of primary forms of headache in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):70-73
Neurofilament light chain: a diagnostic pote­ntial for multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(6):115-119

Multiple sclerosis (MS) is a common neurological disease, especially among people of young working age, and the number of MS cases registered in the world and in the Russian Federation tends to increase. The pathogenesis of MS is based on the theory of damage to its own myelin sheath as a result of activation of autoreactive T cells, which also leads to damage to both oligodendrocytes and axons. In addition, the role of vascular factor in the pathogenesis of MS is discussed in the literature periodically and several areas of research of vascular dysfunction in patients are identified. This article provides a retrospective analysis of the available literature dating from the 19th century to the present time in order to find the relationship between MS and changes in venous circulation

Keywords:

multiple sclerosis
venous circulation
chronic cerebrospinal venous insufficiency
vein
cerebral hypoperfusion

Authors:

Latsh N.Yu.

Pirogov National Research Medical University

Pavlicov A.E.

Pirogov Russian National Research Medical University

Received:

11.04.2023

Accepted:

15.04.2023

List of references:

  1. Gusev EI, Boyko AN. Rasseyannyy skleroz. Nauchno-prakticheskoe rukovodstvo v dvukh tomakh. T. 1. M.: ROOI «Zdorovʹe cheloveka», 2020. (In Russ.).
  2. D’haeseleer M, Cambron M, Vanopdenbosch L, et al. Vascular aspects of multiple sclerosis. Lancet Neurol. 2011;10(7):657-666.  https://doi.org/10.1016/s1474-4422(11)70105-3
  3. Filippi M, Rocca MA. The multiple sclerosis mystery: is there a vascular component? Lancet Neurol. 2011;10(7):597-598.  https://doi.org/10.1016/s1474-4422(11)70124-7
  4. Cruveilhier J. Pathological anatomy of the human body, vol. 2. Paris, France: Billière; 1829—1842. https://archive.org/details/anatomyofhumanbo00cruv/page/n11/mode/2up
  5. Rindfleisch E. Histologisches detail zu der grauen degeneration von Gehirn und Rückenmark. Virchows Archiv A. Pathological Anatomy and Histology. 1863;26:474-483.  https://www.semanticscholar.org/paper/Histologisches-Detail-zu-der-grauen-Degeneration-zu-Rindfleisch/093d7b885724c97bd43ebe93f070ff121b691af7
  6. Ribbert H. Ueber multiple sclerosis des Gehirns und Rückenmarks. Archiv f.pathol.Anat. 1882;90:243-260.  https://doi.org/10.1007/BF01931359
  7. Charcot J. Oeuvres complètes de J-M. Charcot. Bourneville, Paris: Leçons sur les Maladies du Système Nerveux; 1884. https://archive.org/details/leonssurlesmal02char/page/n1/mode/2up
  8. Rae-Grant AD, Wong C, Bernatowicz R, Fox RJ. Observations on the brain vasculature in multiple sclerosis: A historical perspective. Mult Scler Relat Disord. 2014;3(2):156-162.  https://doi.org/10.1016/j.msard.2013.08.005
  9. Dawson JW. The histology of disseminated sclerosis. Transactions of the Royal Society of Edinburgh. 1915;50:517-740.  https://www.semanticscholar.org/paper/XVIII.—The-Histology-of-Disseminated-SclerosisDawson/25be8c4d1ad3a8cca45cee18862fa71279e9405
  10. Falkiewicz T. Zur pathogenese der multiplen Sklerose. Arbeiten aus dem Neurologischen Institute an der Wiener Universität. 1926;28:172-196.  https://archive.org/details/paper-doi—10_1097_00005053-190101000-00040/page/n1/mode/2up
  11. Dow RS, Berglund G. Vascular pattern of lesion of multiple sclerosis. Arch NeurPsych. 1942;47(1):1-18.  https://doi.org/10.1001/archneurpsyc.1942.02290010011001
  12. Zimmerman HM, Netsky MG. The pathology of multiple sclerosis, vol. 28. New York: Research Publications — Association for Research in Nervous and Mental Disease; 1950;28:271-312. PMID: 15413018.
  13. McAlpine D, Compston ND, Lumsden CE. Multiple sclerosis. Edinburgh and London: E & S Livingstone Ltd.; 1955. https://archive.org/details/mcalpinesmultipl0000unsek2f4/page/n5/mode/2up
  14. Fog T. On the vessel — plaque relationships in the brain in multiple sclerosis. Acta Neurologica Scandinavica. 1963;39(S4):257-262.  https://doi.org/10.1111/j.1600-0404.1963.tb01841.x
  15. Adams CW. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci. 1975;25(2):165-182.  https://doi.org/10.1016/0022-510x(75)90138-0
  16. Adams CW, Poston RN, Buk SJ, et al. Inflammatory vasculitis in multiple sclerosis. J Neurol Sci. 1985;69(3):269-283.  https://doi.org/10.1016/0022-510x(85)90139-x
  17. Adams CWM. Perivascular iron deposition and other vascular damage in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 1988;51:260-265.  https://doi.org/10.1136/jnnp.51.2.260
  18. Schelling F. Damaging venous reflux into the skull or spine: relevance to multiple sclerosis. Med Hypotheses. 1986;21(2):141-148.  https://doi.org/10.1016/0306-9877(86)90003-4
  19. Zamboni P, Galeotti R, Menegatti E, et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 2009;80(4):392-399.  https://doi.org/10.1136/jnnp.2008.157164
  20. Zamboni P. The big idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. J R Soc Med. 2006;99(11):589-593.  https://doi.org/10.1177/014107680609901122
  21. Tromba L, Blasi S, Vestri A, et al. Prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: a blinded sonographic evaluation. Phlebology. 2015;30(1):52-60.  https://doi.org/10.1177/0268355513512823
  22. Doepp F, Paul F, Valdueza JM, Schmierer K, Schreiber SJ. No cerebrocervical venous congestion in patients with multiple sclerosis. Ann Neurol. 2010;68(2):173-183.  https://doi.org/10.1002/ana.22085
  23. Wattjes MP, van Oosten BW, de Graaf WL, et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow-quantification study. J Neurol Neurosurg Psychiatry. 2011;82(4):429-435. Epub 2010 Oct 27.  https://doi.org/10.1136/jnnp.2010.223479
  24. Costello F, Modi J, Lautner D, et al. Validity of the diagnostic criteria for chronic cerebrospinal venous insufficiency and association with multiple sclerosis. CMAJ. 2014;186(11):418-426.  https://doi.org/10.1503/cmaj.131431
  25. Zamboni P, Galeotti R, Menegatti E, et al. A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency. J Vasc Surg. 2009;50(6):1348-58.e1-3.  https://doi.org/10.1016/j.jvs.2009.07.096
  26. Dolic K, Weinstock-Guttman B, Marr K, et al. Risk factors for chronic cerebrospinal venous insufficiency (CCSVI) in a large cohort of volunteers. PLoS One. 2011;6(11):e28062. https://doi.org/10.1371/journal.pone.0028062
  27. Laupacis A, Lillie E, Dueck A, et al. Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis. CMAJ. 2011;183(16):1203-1212. https://doi.org/10.1503/cmaj.111074
  28. Talbert DG. Raised venous pressure as a factor in multiple sclerosis. Med Hypotheses. 2008;70(6):1112-1117. https://doi.org/10.1016/j.mehy.2007.10.009
  29. Simka M. Blood brain barrier compromise with endothelial inflammation may lead to autoimmune loss of myelin during multiple sclerosis. Curr Neurovasc Res. 2009;6(2):132-139.  https://doi.org/10.2174/156720209788185605
  30. ElSankari S, Balédent O, Pesch V, et al. Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls. J Cereb Blood Flow Metab. 2013;33(9):1314-1321. https://doi.org/10.1038/jcbfm.2013.95
  31. Engell T, Hvidberg A. Recurrence of periphlebitis retinae in multiple sclerosis. Acta Ophtalmologica. 1985;63(1):80-82.  https://doi.org/10.1111/j.1755-3768.1985.tb05220.x
  32. Engell T. Neurological disease activity in multiple sclerosis patients with periphlebitis retinae. Acta Ophtalmologica. 1986;73(2):168-172.  https://doi.org/10.1111/j.1600-0404.1986.tb03259.x
  33. Singh AV, Zamboni P. Anomalous venous blood flow and iron deposition in multiple sclerosis. J Cereb Blood Flow Metab. 2009;29(12):1867-1878. https://doi.org/10.1038/jcbfm.2009.180
  34. Craelius W, Migdal MW, Luessenhop CP, et al. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med. 1982;106(8):397-399. 
  35. Haacke EM, Garbern J, Miao Y, et al. Iron stores and cerebral veins in MS studied by susceptibility weighted imaging. Int Angiol. 2010;29(2):149-157. 
  36. Zivadinov R, Schirda C, Dwyer MG, et al. Chronic cerebrospinal venous insufficiency and iron deposition on susceptibility-weighted imaging in patients with multiple sclerosis: a pilot case-control study. Int Angiol. 2010;29(2):158-175. 
  37. Khalil M, Teunissen C, Langkammer C. Iron and neurodegeneration in multiple sclerosis. Mult Scler Int. 2011;2011:606807. https://doi.org/10.1155/2011/606807
  38. Baracchini C, Perini P, Calabrese M, et al. No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Ann Neurol. 2011;69(1):90-99.  https://doi.org/10.1002/ana.22228
  39. Zivadinov R, Marr K, Cutter G, et al. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology. 2011;77(2):138-144.  https://doi.org/10.1212/wnl.0b013e318212a901
  40. Baracchini C, Valdueza JM, Del Sette M, et al. CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics. J Neurol. 2012;259(12):2585-2589. https://doi.org/10.1007/s00415-012-6541-3
  41. Yamout B, Herlopian A, Issa Z, et al. Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Mult Scler. 2010;16(11):1341-1348. https://doi.org/10.1177/1352458510385268
  42. Christensen S, Farkas DK, Pedersen L, et al. Multiple sclerosis and risk of venous thromboembolism: a population-based cohort study. Neuroepidemiology. 2012;38(2):76-83.  https://doi.org/10.1159/000335496
  43. Minagar A, Jy W, Jimenez JJ, Sheremata WA, et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology. 2001;56(10):1319-1324. https://doi.org/10.1212/wnl.56.10.1319
  44. Aksungar FB, Topkaya AE, Yildiz Z, et al. Coagulation status and biochemical and inflammatory markers in multiple sclerosis. J Clin Neurosci. 2008;15(4):393-397.  https://doi.org/10.1016/j.jocn.2007.02.090
  45. Ramsaransing GS, Fokkema MR, Teelken A, et al. Plasma homocysteine levels in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2006;77(2):189-192.  https://doi.org/10.1136/jnnp.2005.072199
  46. Chapman J. Thrombin in inflammatory brain diseases. Autoimmun Rev. 2006;5(8):528-531.  https://doi.org/10.1016/j.autrev.2006.02.011
  47. Sheremata WA, Jy W, Horstman LL, et al. Evidence of platelet activation in multiple sclerosis. J Neuroinflammation. 2008;5:27.  https://doi.org/10.1186/1742-2094-5-27
  48. Huerta C, Johansson S, Wallander MA, et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007;167(9):935-943.  https://doi.org/10.1001/archinte.167.9.935
  49. Johannesdottir SA, Horváth-Puhó E, Dekkers OM, et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med. 2013;173(9):743-752.  https://doi.org/10.1001/jamainternmed.2013.122
  50. van Zaane B, Nur E, Squizzato A, et al. Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost. 2010;8(11):2483-2493. https://doi.org/10.1111/j.1538-7836.2010.04034.x
  51. Kaufman J, Khatri BO, Riendl P. Are patients with multiple sclerosis protected from thrombophlebitis and pulmonary embolism? Chest. 1988;94(5):998-1001. https://doi.org/10.1378/chest.94.5.998
  52. Aglamis S, Gönen M. Flow volume measurement of arterial venous and cerebrospinal fluid in patients with multiple sclerosis Arq Neuropsiquiatr. 2022;80(7):706-711.  https://doi.org/10.1055/s-0042-1755276
  53. Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162-173.  https://doi.org/10.1016/S1474-4422(17)30470-2
  54. Tallantyre EC, Brookes MJ, Dixon JE, et al. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology. 2008;70(22):2076-2078. https://doi.org/10.1212/01.wnl.0000313377.49555.2e
  55. Oh J, Sicotte NL. New imaging approaches for precision diagnosis and disease staging of MS? Mult Scler. 2020;26(5):568-575.  https://doi.org/10.1177/1352458519871817
  56. Maggi P, Absinta M, Sati P, et al. The «central vein sign» in patients with diagnostic «red flags» for multiple sclerosis: A prospective multicenter 3T study. Mult Scler. 2020;26(4):421-32.  https://doi.org/10.1177/1352458519876031
  57. Tallantyre EC, Dixon JE, Donaldson I, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76(6):534.  https://doi.org/10.1212/wnl.0b013e31820b7630
  58. Al-Louzi O, Letchuman V, Manukyan S, et al. Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis: A 3-Year Longitudinal Study. Neurol Neuroimmunol Neuroinflamm. 2022;9(2):e1120. https://doi.org/10.1212/nxi.0000000000001120
  59. Belov SE, Boyko AN. A symptom of the central vein in various diseases and protocols of MRI studies. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. Spetsvypusk. 2022;122(7-2):19-26. (In Russ.). https://doi.org/10.17116/jnevro202212207219

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.